⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DAWN News
Day One Biopharmaceuticals, Inc. Common Stock
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Talkspace, Inc. (Nasdaq - TALK), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN), Kennedy-Wilson Holdings, Inc. (NYSE - KW), United Homes Group, Inc. (Nasdaq - UHG)
globenewswire.com
TALK
DAWN
KW
UHG
UHS
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
businesswire.com
DAWN
Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
DAWN
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
prnewswire.com
DAWN
Servier et Day One Biopharmaceuticals annoncent un accord d'acquisition qui renforce le portefeuille de Servier dans les cancers rares USA - Français USA - English
prnewswire.com
DAWN
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
DAWN
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio
prnewswire.com
DAWN
Form 8-K
sec.gov
DAWN
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
globenewswire.com
DAWN
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
globenewswire.com
DAWN